Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1993-9-30
|
pubmed:abstractText |
To determine whether detection of IgM type antibody (Ab) to hepatitis C virus (HCV) antigens would be useful in the early diagnosis of type C acute hepatitis (AH) or fulminant hepatitis (FH), we assayed serum IgM and IgG type Abs to nonstructural (C100-3) and core (AR 142) antigens of HCV in patients with type C hepatitis. Of 8 patients with AH, anti-C100-3 IgM and anti-AR 142 IgM were positive in 1 and 6 patients, respectively. Early appearance of Anti-AR 142 IgM was observed in all of these 6 patients, and in 4 anti-AR 142 IgM was the sole serological marker of HCV infection during the acute-phase. However, the anti-AR 142 IgM response was rather persistent, not transient in AH. Only 1 patient with AH was positive for anti-C100-3 IgM, and this patient became positive for anti-AR 142 IgM 3 months before the appearance of anti-C100-3 IgM. The titre of anti-AR 142 IgM in AH was not dependent on the activity of hepatitis or on the duration. Anti-AR 142 IgM was also positive in 30-75% cases with chronic HCV carriers. Thus it is suggested that the detection of anti-AR 142 IgM may contribute to the early diagnosis of type C AH, although the appearance of this marker in chronic HCV carriers limits its usefulness as the sole serological marker of acute HCV infection.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antigens, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/C100 protein, hepatitis C virus,
http://linkedlifedata.com/resource/pubmed/chemical/Hepatitis Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Hepatitis C Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Hepatitis C Antigens,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin G,
http://linkedlifedata.com/resource/pubmed/chemical/Immunoglobulin M,
http://linkedlifedata.com/resource/pubmed/chemical/Viral Nonstructural Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0435-1339
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
28 Suppl 5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
71-5
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7689511-Acute Disease,
pubmed-meshheading:7689511-Adult,
pubmed-meshheading:7689511-Antigens, Viral,
pubmed-meshheading:7689511-Hepacivirus,
pubmed-meshheading:7689511-Hepatitis Antibodies,
pubmed-meshheading:7689511-Hepatitis C,
pubmed-meshheading:7689511-Hepatitis C Antibodies,
pubmed-meshheading:7689511-Hepatitis C Antigens,
pubmed-meshheading:7689511-Humans,
pubmed-meshheading:7689511-Immunoglobulin G,
pubmed-meshheading:7689511-Immunoglobulin M,
pubmed-meshheading:7689511-Time Factors,
pubmed-meshheading:7689511-Viral Nonstructural Proteins
|
pubmed:year |
1993
|
pubmed:articleTitle |
Anti-HCV immunoglobulin M antibody in patients with acute and fulminant hepatitis C.
|
pubmed:affiliation |
Third Department of Internal Medicine, Ehime University School of Medicine, Japan.
|
pubmed:publicationType |
Journal Article
|